FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE and CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION

1 reports of this reaction

1.9% of all FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE reports

#9 most reported adverse reaction

Overview

CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION is the #9 most commonly reported adverse reaction for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, manufactured by CVS Pharmacy. There are 1 FDA adverse event reports linking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE to CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION. This represents approximately 1.9% of all 52 adverse event reports for this drug.

Patients taking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE who experience cystic fibrosis respiratory infection suppression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION1 of 52 reports

CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION is a less commonly reported adverse event for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, but still significant enough to appear in the safety profile.

Other Side Effects of FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE

In addition to cystic fibrosis respiratory infection suppression, the following adverse reactions have been reported for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE:

Other Drugs Associated with CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION

The following drugs have also been linked to cystic fibrosis respiratory infection suppression in FDA adverse event reports:

LUMACAFTOR AND IVACAFTOR

Frequently Asked Questions

Does FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE cause CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION?

CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION has been reported as an adverse event in 1 FDA reports for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION with FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE?

CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION accounts for approximately 1.9% of all adverse event reports for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, making it a notable side effect.

What should I do if I experience CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION while taking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE?

If you experience cystic fibrosis respiratory infection suppression while taking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE Full ProfileAll Drugs Causing CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSIONCVS Pharmacy Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.